You are at the threshold of an FDA Advisory Committee Meeting.
Perhaps it is for a new drug or device indication. Or maybe the focus will be a safety update.
Regardless-- the costs of getting your drug or device to this point have reached into the hundreds of millions of dollars.
The time spent on research and clinical trials may well have exceeded a decade.
The investment is almost incomprehensible.
And now, it is all on the line—which is exactly why companies just like you call us. |
